Altimmune, Inc. (ALT)
NASDAQ: ALT · IEX Real-Time Price · USD
6.75
+0.06 (0.90%)
At close: Jul 26, 2024, 4:00 PM
6.74
-0.01 (-0.15%)
After-hours: Jul 26, 2024, 7:08 PM EDT
Altimmune Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.41 | 0.43 | -0.07 | 4.41 | 8.19 | 5.8 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -46.12% | 41.09% | -43.85% | Upgrade
|
| Cost of Revenue | 70.04 | 65.8 | 70.45 | 73.84 | 33.51 | 17.07 | Upgrade
|
| Gross Profit | -69.63 | -65.37 | -70.52 | -69.43 | -25.32 | -11.26 | Upgrade
|
| Selling, General & Admin | 18.92 | 18.14 | 17.13 | 15.41 | 13.21 | 8.5 | Upgrade
|
| Operating Expenses | 18.92 | 18.14 | 17.13 | 15.41 | 13.21 | 8.5 | Upgrade
|
| Operating Income | -88.55 | -83.51 | -87.65 | -84.84 | -38.53 | -19.76 | Upgrade
|
| Interest Expense | -0.03 | -0.04 | -0.01 | -0.01 | -0.01 | -0 | Upgrade
|
| Interest & Investment Income | 8.1 | 7.35 | 2.87 | 0.2 | 0.32 | 0.84 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.14 | 0.17 | -0.03 | -0.37 | 0.02 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | -80.35 | -76.03 | -84.82 | -85.02 | -38.2 | -18.88 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -0.7 | Upgrade
|
| Asset Writedown | -12.42 | -12.42 | - | -11.37 | - | -1 | Upgrade
|
| Other Unusual Items | - | - | -0.09 | -0.7 | -16.27 | - | Upgrade
|
| Pretax Income | -92.77 | -88.45 | -84.91 | -97.09 | -54.46 | -20.58 | Upgrade
|
| Income Tax Expense | - | - | -0.2 | - | -5.42 | -0.06 | Upgrade
|
| Net Income | -92.77 | -88.45 | -84.71 | -97.09 | -49.04 | -20.52 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.45 | Upgrade
|
| Net Income to Common | -92.77 | -88.45 | -84.71 | -97.09 | -49.04 | -20.97 | Upgrade
|
| Shares Outstanding (Basic) | 58 | 53 | 47 | 41 | 26 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 53 | 47 | 41 | 26 | 13 | Upgrade
|
| Shares Change (YoY) | 20.53% | 13.47% | 13.67% | 61.03% | 95.33% | 368.35% | Upgrade
|
| EPS (Basic) | -1.59 | -1.66 | -1.81 | -2.35 | -1.91 | -1.60 | Upgrade
|
| EPS (Diluted) | -1.59 | -1.66 | -1.81 | -2.35 | -1.91 | -1.60 | Upgrade
|
| Free Cash Flow | -72.76 | -75.86 | -62.71 | -90.36 | -34.51 | -9.6 | Upgrade
|
| Free Cash Flow Per Share | -1.25 | -1.42 | -1.34 | -2.19 | -1.35 | -0.73 | Upgrade
|
| Gross Margin | - | - | - | - | - | -194.16% | Upgrade
|
| Operating Margin | -21596.34% | -19603.29% | - | -1923.90% | -470.78% | -340.69% | Upgrade
|
| Free Cash Flow Margin | -17745.37% | -17806.81% | - | -2048.87% | -421.62% | -165.53% | Upgrade
|
| EBITDA | -88.09 | -83.03 | -87.16 | -84.29 | -38.1 | -19.38 | Upgrade
|
| D&A For EBITDA | 0.46 | 0.48 | 0.49 | 0.55 | 0.43 | 0.39 | Upgrade
|
| EBIT | -88.55 | -83.51 | -87.65 | -84.84 | -38.53 | -19.76 | Upgrade
|
Source: S&P Capital IQ. Standard template.